Search

Background: Urinary incontinence affects up to half of women, yet few speak to their health care provider about or receive treatment for the condition. To aid with identifying subpopulations at risk for urinary incontinence, we examined the associations between 10 chronic health conditions and urinary incontinence among Canadian adult females., Methods: We conducted a cross-sectional analysis of survey data from the Canadian Community Health Survey (2013-2014) involving female respondents aged 25 years or older living in a private dwelling. Presence of chronic conditions and urinary incontinence were measured by self-report. We used logistic regression modelling with sampling weights, controlling for age, income, ethnicity, body mass index and smoking. Multiple imputation and probabilistic bias analysis were used to address missing covariate data and unmeasured confounding from parity., Results: Our analysis included 60 186 respondents representing more than 12 million Canadian females, of whom 45.8% (95% confidence interval [CI] 45.0%-46.6%) reported at least 1 chronic condition. Chronic conditions were associated with more than twice the odds of urinary incontinence (adjusted odds ratio [OR] 2.42, 95% CI 2.02-2.89). Associations were largest for bowel disorders (adjusted OR 2.92, 95% CI 2.44-3.49); modest for chronic obstructive pulmonary disease (adjusted OR 2.00, 95% CI 1.63-2.45), asthma (adjusted OR 1.82, 95% CI 1.52-2.19), arthritis (adjusted OR 1.98, 95% CI 1.74-2.24) and heart disease (adjusted OR 1.73, 95% CI 1.48-2.02); and smallest for diabetes (adjusted OR 1.20, 95% CI 1.02-1.41) and high blood pressure (adjusted OR 1.27, 95% CI 1.12-1.44). Results slightly attenuated but did not substantively change after imputation and bias analysis., Interpretation: We found that chronic conditions are associated with significantly higher odds of comorbid urinary incontinence among Canadian adult females, which is consistent with previous research. Our findings support routine inquiry regarding urinary incontinence symptoms among women accessing health care for chronic conditions., Competing Interests: Competing interests: Cynthia Seow has served on advisory boards for Janssen, AbbVie, Takeda, Ferring, Shire, Pfizer, Sandoz, Pharmascience, Fresenius Kabi and Amgen, and as a speaker for Janssen, AbbVie, Takeda, Ferring, Shire, Pfizer and Pharmascience. Erin Brennand has served as a speaker for SearchLight Pharmaceuticals. These connections are outside of the current work. No other competing interests were declared., (© 2022 CMA Impact Inc. or its licensors.)

Competing Interests: Intérêts concurrents: Anne Pham-Huy déclare avoir reçu des honoraires de la Société canadienne d’allergie et d’immunologie clinique et de l’Université de Calgary pour des présentations. Elle est présidente d’Immunisation Canada. Karina Top est co-investigatrice pour des projets subventionnés par GSK, indépendamment des travaux soumis. Elle déclare également avoir reçu des honoraires de la Société canadienne d’allergie et d’immunologie clinique, une rémunération du ministère de la Procureure générale de l’Ontario pour avoir témoigné en tant qu’experte et des honoraires à titre de conférencière de l’Association canadienne de la santé publique, indépendamment des travaux soumis. Elle est directrice du Conseil de l’AMMI Canada et membre de l’Association canadienne pour la recherche, l’évaluation et l’éducation en immunisation. Cora Constantinescu déclare avoir reçu des honoraires à titre de conférencière de GSK et Pfizer. Cynthia Seow fait partie de comités consultatifs et déclare avoir reçu des honoraires à titre de conférencière de Janssen, Abbvie, Takeda, Ferring, Shire, Pfizer, Sandoz, Pharmascience. Aucun autre intérêt concurrent n’a été déclaré.

Competing Interests: Competing interests: Anne Pham-Huy reports presentation honoraria from the Canadian Society of Allergy and Clinical Immunology and the University of Calgary. She is the chair of Immunize Canada. Karina Top is a co-investigator on grants from GSK, outside the submitted work. She also reports an honorarium from the Canadian Society of Allergy and Clinical Immunology, payment for expert testimony from the Ontario Ministry of the Attorney General and conference support from the Canadian Public Health Association, outside the submitted work. She is the director of the AMMI Canada Council and a member of the Canadian Association for Immunization Research Evaluation and Education. Cora Constantinescu reports speaker fees from GSK and Pfizer. Cynthia Seow sits on the advisory boards for and reports speaker fees from Janssen, Abbvie, Takeda, Ferring, Shire, Pfizer, Sandoz, Pharmascience. No other competing interests were declared.

Competing Interests: Competing interests: The authors are involved in a research project supported by the MSI Foundation and the American College of Gastroenterology regarding improving clinical pathways in IBD care during pregnancy. Cynthia Seow has received honoraria as an advisory board member for Janssen Pharmaceutical, AbbVie, Shire, Actavis, Takeda Canada and Ferring Pharmaceuticals; speaker fees from Janssen Pharmaceutical and AbbVie; and research and educational support from Janssen Pharmaceutical and AbbVie. No other competing interests were declared.